Hemostemix Inc V.HEM

Alternate Symbol(s): HMTXF

Healthcare Biotechnology

Hemostemix Inc. is a Canada-based clinical-stage biotechnology company. The Company’s principal business is to develop, manufacture and commercialize blood-derived stem cell therapies to treat various diseases. It is an autologous stem cell therapeutics company that holds 91 patents on the derivation of three stem cell lineages from the patient’s blood, including angiogenic cell precursors (ACP-01), neuronal cell precursors, and cardiomyocyte cell precursors. ACP-01 is a lead clinical-stage candidate, like NCP-01 and CCP-01, is generated from the patient’s blood. The Company is engaged in providing treatment for ischemia, such as ischemic cardiomyopathy, angina, peripheral arterial disease including critical limb ischemia. The Company’s proprietary technology is a personalized regenerative therapy that is administered to a patient within seven days of the initial blood draw. Its subsidiaries include Kwalata Trading Limited, Hemostemix Ltd., and PreCerv Inc.

TSXV:HEM - Post by User

Hemostemix Inc

<< Previous

Bullboard Posts

Next >>

Post by Budamanon Sep 28, 2021 8:59am

365 Views

Post# 33929616

Data Capture should be at 80%

By the end of the month - they seem to be averaging 10% per month. They should have full data recovery by the end of November. This going to be one heck of a Christmas! I see a SP between $3 and $7 based on the outstanding results. I will guess an average of 8/10 saved limbs from amputation. This is incredible. In my opinion only. Thanks-Buda.

<< Previous

Bullboard Posts

Next >>

Who, why, and what of the great "Crypto Surge"